Purine Antimetabolite [EPC]

Purine Antimetabolite [EPC] was reported 98853 times

Drugs of the Purine Antimetabolite [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9080
1 GRIP STRENGTH 119 0.5197
2 HEPATOSPLENIC T-CELL LYMPHOMA 155 0.4178
3 PULMONARY VASCULITIS 222 0.4126
4 BLOOD IRON ABNORMAL 359 0.3675
5 LUPUS VULGARIS 457 0.3627
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 240 0.3593
7 TOTAL LUNG CAPACITY ABNORMAL 135 0.3470
8 RETINITIS 514 0.2973
9 SLE ARTHRITIS 84 0.2958
10 CAPILLARITIS 81 0.2935
11 ILEOCAECAL RESECTION 94 0.2733
12 ELBOW DEFORMITY 88 0.2543
13 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 108 0.2353
14 BONE EROSION 827 0.2336
15 CHOLESTASIS OF PREGNANCY 106 0.2304
16 SERONEGATIVE ARTHRITIS 264 0.2304
17 OVERLAP SYNDROME 161 0.2300
18 NODULAR REGENERATIVE HYPERPLASIA 144 0.2243
19 SPIROMETRY ABNORMAL 134 0.2241
20 GRANULOMA SKIN 181 0.2205
21 DEEP VEIN THROMBOSIS POSTOPERATIVE 425 0.2122
22 FACET JOINT SYNDROME 679 0.2083
23 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 431 0.2078
24 RHEUMATIC FEVER 908 0.2035
25 MITE ALLERGY 129 0.1969
26 DISLOCATION OF VERTEBRA 447 0.1958
27 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 132 0.1801
28 CLEAR CELL RENAL CELL CARCINOMA 114 0.1638
29 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 332 0.1627
30 X-RAY ABNORMAL 290 0.1620
31 TENOSYNOVITIS STENOSANS 88 0.1580
32 TERMINAL ILEITIS 96 0.1564
33 ILEAL STENOSIS 277 0.1557
34 MYCOTIC ALLERGY 128 0.1497
35 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1060 0.1478
36 SWOLLEN JOINT COUNT INCREASED 458 0.1435
37 C-REACTIVE PROTEIN ABNORMAL 921 0.1434
38 LUNG TRANSPLANT REJECTION 93 0.1409
39 RHEUMATOID FACTOR POSITIVE 804 0.1391
40 NEURITIS 213 0.1379
41 DUODENAL ULCER PERFORATION 1001 0.1345
42 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 79 0.1337
43 PERIPHERAL VENOUS DISEASE 541 0.1323
44 DRUG TOLERANCE DECREASED 371 0.1320
45 DUST ALLERGY 127 0.1295
46 BLOOD PARATHYROID HORMONE DECREASED 190 0.1281
47 FAECAL CALPROTECTIN INCREASED 400 0.1262
48 LUPUS NEPHRITIS 228 0.1218
49 ONYCHOMADESIS 498 0.1185
50 GRANULOMATOSIS WITH POLYANGIITIS 141 0.1168
51 INTESTINAL STENOSIS 490 0.1161
52 CUSHINGOID 355 0.1105
53 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 560 0.1099
54 RHEUMATOID NODULE 303 0.1099
55 BREAST CANCER STAGE III 690 0.1064
56 C-REACTIVE PROTEIN 98 0.1057
57 CONJUNCTIVITIS ALLERGIC 155 0.1046
58 PEMPHIGUS 1289 0.1030
59 ANAL FISTULA 543 0.1017
60 CHRONIC ALLOGRAFT NEPHROPATHY 79 0.1009
61 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 231 0.1002
62 HELICOBACTER INFECTION 1025 0.0996
63 SMALL INTESTINAL STENOSIS 106 0.0995
64 HYPERCHOLESTEROLAEMIA 959 0.0992
65 SCLERITIS 159 0.0992
66 SYNOVITIS 1789 0.0991
67 ONYCHOMYCOSIS 431 0.0981
68 LARGE INTESTINAL STENOSIS 196 0.0980
69 HAND DEFORMITY 1285 0.0979
70 INTESTINAL FISTULA 137 0.0972
71 PANNICULITIS 234 0.0966
72 MUSCLE INJURY 800 0.0965
73 GRIP STRENGTH DECREASED 824 0.0935
74 DRUG LEVEL BELOW THERAPEUTIC 512 0.0927
75 PORPHYRIA ACUTE 132 0.0920
76 ENTEROCUTANEOUS FISTULA 81 0.0918
77 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1009 0.0911
78 JC VIRUS INFECTION 145 0.0906
79 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 160 0.0904
80 FISTULA DISCHARGE 114 0.0903
81 FOLLICULITIS 941 0.0896
82 RESPIRATORY SYMPTOM 252 0.0885
83 CYTOMEGALOVIRUS COLITIS 201 0.0873
84 LIVE BIRTH 694 0.0829
85 LUPUS-LIKE SYNDROME 749 0.0825
86 HISTOPLASMOSIS DISSEMINATED 128 0.0806
87 LYMPHOPROLIFERATIVE DISORDER 235 0.0799
88 ANAL ABSCESS 427 0.0791
89 WOUND INFECTION 863 0.0787
90 ANAL FISSURE 418 0.0779
91 PERICARDITIS 1280 0.0761
92 GASTROINTESTINAL WALL THICKENING 114 0.0761
93 JOINT RANGE OF MOTION DECREASED 1018 0.0758
94 BLEPHAROSPASM 474 0.0752
95 EXOSTOSIS 686 0.0750
96 FISTULA 841 0.0747
97 SMALL INTESTINAL RESECTION 87 0.0746
98 MATERNAL EXPOSURE TIMING UNSPECIFIED 277 0.0737
99 BLOOD PRESSURE DIASTOLIC ABNORMAL 186 0.0731
100 LIP DRY 662 0.0728
101 DISSEMINATED TUBERCULOSIS 179 0.0697
102 JOINT DISLOCATION 729 0.0689
103 ERYTHEMA NODOSUM 242 0.0689
104 CROHN'S DISEASE 470 0.0685
105 BURSITIS 831 0.0684
106 EPSTEIN-BARR VIRUS INFECTION 418 0.0668
107 FINGER DEFORMITY 319 0.0658
108 ILEOSTOMY 166 0.0650
109 NEUROMYELITIS OPTICA SPECTRUM DISORDER 87 0.0645
110 NOCARDIOSIS 165 0.0645
111 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 150 0.0644
112 ASPERGILLOSIS 84 0.0643
113 THERAPEUTIC REACTION TIME DECREASED 185 0.0634
114 DEMYELINATION 259 0.0631
115 PLEURITIC PAIN 171 0.0619
116 FOOT DEFORMITY 686 0.0618
117 RECTAL ABSCESS 103 0.0613
118 ENTHESOPATHY 95 0.0607
119 MYASTHENIA GRAVIS CRISIS 90 0.0607
120 FEMALE GENITAL TRACT FISTULA 103 0.0603
121 COLITIS ULCERATIVE 2674 0.0598
122 DRUG SPECIFIC ANTIBODY PRESENT 385 0.0591
123 CYTOMEGALOVIRUS VIRAEMIA 263 0.0591
124 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 378 0.0581
125 AUTOIMMUNE DISORDER 567 0.0581
126 DRUG LEVEL ABOVE THERAPEUTIC 264 0.0576
127 VASCULITIS 664 0.0569
128 CHOLANGITIS SCLEROSING 117 0.0569
129 TENOSYNOVITIS 157 0.0569
130 PULMONARY FIBROSIS 1091 0.0568
131 LYMPHADENITIS 137 0.0565
132 DRUG LEVEL DECREASED 575 0.0564
133 NORMAL NEWBORN 306 0.0562
134 STEROID DIABETES 84 0.0560
135 NORMOCHROMIC NORMOCYTIC ANAEMIA 168 0.0559
136 MYCOBACTERIAL INFECTION 96 0.0557
137 SPONDYLITIS 202 0.0555
138 FORCED EXPIRATORY VOLUME DECREASED 157 0.0554
139 HISTIOCYTOSIS HAEMATOPHAGIC 163 0.0548
140 SYSTEMIC LUPUS ERYTHEMATOSUS 1942 0.0547
141 VARICELLA ZOSTER VIRUS INFECTION 113 0.0545
142 CONTRAINDICATED PRODUCT ADMINISTERED 1643 0.0542
143 KIDNEY TRANSPLANT REJECTION 259 0.0539
144 PNEUMONIA CYTOMEGALOVIRAL 102 0.0525
145 GLOSSODYNIA 1170 0.0522
146 INFUSION SITE REACTION 156 0.0522
147 GASTROINTESTINAL STOMA COMPLICATION 82 0.0521
148 HISTOPLASMOSIS 92 0.0519
149 C-REACTIVE PROTEIN INCREASED 1885 0.0518
150 TRANSPLANT REJECTION 414 0.0516
151 STENOSIS 97 0.0516
152 CYTOMEGALOVIRUS INFECTION 849 0.0510
153 GASTROINTESTINAL INFLAMMATION 398 0.0508
154 INTESTINAL RESECTION 272 0.0505
155 NAIL DISORDER 439 0.0501
156 ANTINUCLEAR ANTIBODY POSITIVE 162 0.0498
157 ABDOMINAL ADHESIONS 157 0.0497
158 LIVER FUNCTION TEST INCREASED 1046 0.0487
159 PROCTITIS 136 0.0485
160 ABSCESS INTESTINAL 104 0.0483
161 FIBROMYALGIA 1174 0.0482
162 PULMONARY ALVEOLAR HAEMORRHAGE 268 0.0477
163 LYMPHOPENIA 671 0.0474
164 PYODERMA GANGRENOSUM 170 0.0472
165 CYTOMEGALOVIRUS CHORIORETINITIS 92 0.0471
166 PULMONARY TUBERCULOSIS 199 0.0465
167 IRRITABLE BOWEL SYNDROME 993 0.0463
168 WOUND 1293 0.0462
169 THERAPEUTIC PRODUCT EFFECT DECREASED 2070 0.0462
170 NEUROLOGICAL SYMPTOM 264 0.0461
171 BACK INJURY 502 0.0461
172 BODY TEMPERATURE FLUCTUATION 96 0.0460
173 SQUAMOUS CELL CARCINOMA OF SKIN 278 0.0460
174 CONGENITAL ANOMALY 354 0.0457
175 WALKING AID USER 301 0.0456
176 PRE-ECLAMPSIA 216 0.0454
177 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 150 0.0454
178 COMPLICATIONS OF TRANSPLANTED KIDNEY 102 0.0449
179 BLOOD PRESSURE SYSTOLIC ABNORMAL 111 0.0449
180 B-CELL LYMPHOMA 152 0.0447
181 SKIN NECROSIS 232 0.0447
182 PNEUMOCYSTIS JIROVECII PNEUMONIA 449 0.0447
183 DIFFUSE LARGE B-CELL LYMPHOMA 344 0.0446
184 LIVER TRANSPLANT REJECTION 80 0.0445
185 BASAL CELL CARCINOMA 692 0.0443
186 PRODUCT LABEL CONFUSION 257 0.0441
187 DERMATOMYOSITIS 111 0.0438
188 HEPATIC CIRRHOSIS 812 0.0432
189 LARGE INTESTINAL ULCER 117 0.0431
190 ANORECTAL DISORDER 85 0.0426
191 LOW BIRTH WEIGHT BABY 337 0.0424
192 APHTHOUS ULCER 328 0.0422
193 DIARRHOEA HAEMORRHAGIC 392 0.0419
194 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 345 0.0418
195 FREQUENT BOWEL MOVEMENTS 1129 0.0418
196 ACTINIC KERATOSIS 108 0.0416
197 OBESITY 660 0.0414
198 MUCOUS STOOLS 204 0.0411
199 ABSCESS 652 0.0408
200 AUTOIMMUNE HEPATITIS 284 0.0408
201 FOETAL GROWTH RESTRICTION 244 0.0401
202 LIVER INJURY 975 0.0397
203 TREATMENT FAILURE 3287 0.0396
204 DEFAECATION URGENCY 278 0.0396
205 SUBCUTANEOUS ABSCESS 190 0.0396
206 LOSS OF THERAPEUTIC RESPONSE 126 0.0395
207 INFUSION RELATED REACTION 2612 0.0394
208 CREPITATIONS 117 0.0392
209 DRUG INTOLERANCE 3787 0.0392
210 SQUAMOUS CELL CARCINOMA 369 0.0392
211 PREMATURE LABOUR 220 0.0389
212 IMPAIRED HEALING 1270 0.0386
213 MYASTHENIA GRAVIS 312 0.0386
214 PORTAL HYPERTENSION 119 0.0385
215 INTENTIONAL PRODUCT USE ISSUE 3369 0.0384
216 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 95 0.0384
217 ABDOMINAL ABSCESS 169 0.0382
218 HEPATOSPLENOMEGALY 98 0.0381
219 SCIATICA 601 0.0377
220 FOOD INTOLERANCE 138 0.0376
221 SERUM SICKNESS 105 0.0376
222 CYTOMEGALOVIRUS INFECTION REACTIVATION 166 0.0375
223 APLASIA PURE RED CELL 129 0.0375
224 LYMPHOCYTE COUNT DECREASED 659 0.0372
225 CERVICAL DYSPLASIA 81 0.0371
226 BLOOD PRESSURE DIASTOLIC INCREASED 171 0.0370
227 COELIAC DISEASE 362 0.0369
228 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 276 0.0367
229 COLECTOMY 207 0.0366
230 PREMATURE DELIVERY 580 0.0364
231 VARICELLA 87 0.0364
232 JOINT STIFFNESS 946 0.0360
233 INFLAMMATION 1861 0.0360
234 BRAIN ABSCESS 91 0.0359
235 GRANULOMA 124 0.0358
236 BLOOD PRESSURE DIASTOLIC DECREASED 259 0.0351
237 PNEUMOCYSTIS JIROVECI PNEUMONIA 78 0.0350
238 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 82 0.0350
239 BLOOD PRESSURE FLUCTUATION 834 0.0347
240 ARTHROPATHY 1926 0.0346
241 TYPE 2 DIABETES MELLITUS 1152 0.0342
242 HYPOGAMMAGLOBULINAEMIA 223 0.0339
243 TRANSPLANT FAILURE 83 0.0338
244 SPINAL FUSION SURGERY 137 0.0337
245 LOWER RESPIRATORY TRACT INFECTION 1533 0.0337
246 DRUG-INDUCED LIVER INJURY 1056 0.0336
247 PSORIATIC ARTHROPATHY 1355 0.0333
248 OSTEOARTHRITIS 1410 0.0332
249 MYCOBACTERIUM AVIUM COMPLEX INFECTION 89 0.0331
250 PREMATURE RUPTURE OF MEMBRANES 78 0.0323
251 RHEUMATOID ARTHRITIS 3657 0.0322
252 HEPATITIS 824 0.0322
253 ENTERITIS 206 0.0322
254 POOR VENOUS ACCESS 333 0.0321
255 HYPERSENSITIVITY VASCULITIS 84 0.0320
256 PNEUMATOSIS INTESTINALIS 91 0.0319
257 CUTANEOUS VASCULITIS 115 0.0315
258 POLYARTHRITIS 166 0.0315
259 PROCTALGIA 199 0.0309
260 DYSCHEZIA 94 0.0308
261 IMMUNOSUPPRESSION 269 0.0305
262 UVEITIS 413 0.0304
263 CLOSTRIDIUM DIFFICILE INFECTION 661 0.0303
264 EXPOSURE DURING PREGNANCY 1870 0.0301
265 FULL BLOOD COUNT ABNORMAL 317 0.0299
266 DRUG TOLERANCE 151 0.0298
267 SMALL INTESTINAL OBSTRUCTION 367 0.0298
268 NIGHT SWEATS 957 0.0297
269 HEPATIC ENZYME INCREASED 2008 0.0294
270 HEPATIC FIBROSIS 101 0.0294
271 HIP ARTHROPLASTY 446 0.0291
272 DRUG ERUPTION 514 0.0290
273 AUTOIMMUNE HAEMOLYTIC ANAEMIA 99 0.0289
274 GAIT INABILITY 961 0.0287
275 MATERNAL EXPOSURE DURING PREGNANCY 2558 0.0287
276 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2008 0.0282
277 SYNOVIAL CYST 130 0.0281
278 PREMATURE BABY 844 0.0280
279 IRON DEFICIENCY 125 0.0278
280 OSTEOPOROSIS 1135 0.0276
281 OBSTRUCTION 110 0.0275
282 KLEBSIELLA INFECTION 139 0.0275
283 ULCER 436 0.0274
284 THROMBOTIC MICROANGIOPATHY 267 0.0274
285 LUNG DISORDER 1341 0.0273
286 BLOOD CHOLESTEROL INCREASED 1272 0.0273
287 EAR INFECTION 726 0.0273
288 ESCHERICHIA SEPSIS 79 0.0272
289 HERPES SIMPLEX 177 0.0272
290 SKIN PAPILLOMA 109 0.0272
291 BRONCHIECTASIS 182 0.0270
292 NODULE 350 0.0268
293 ASPERGILLUS INFECTION 176 0.0268
294 MATERNAL EXPOSURE BEFORE PREGNANCY 181 0.0265
295 BRONCHOPULMONARY ASPERGILLOSIS 205 0.0264
296 BODY TEMPERATURE DECREASED 258 0.0262
297 BLOOD PRESSURE SYSTOLIC INCREASED 508 0.0260
298 BREATH SOUNDS ABNORMAL 128 0.0259
299 HAEMATOCHEZIA 1432 0.0259
300 LOWER LIMB FRACTURE 497 0.0258
301 LEUKOPENIA 1288 0.0257
302 THERAPY NON-RESPONDER 1157 0.0257
303 ARTERIOSCLEROSIS CORONARY ARTERY 170 0.0256
304 PRESCRIBED UNDERDOSE 510 0.0255
305 PSEUDOMONAS INFECTION 219 0.0255
306 TONSILLITIS 132 0.0253
307 INTESTINAL OBSTRUCTION 931 0.0247
308 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 418 0.0246
309 OESOPHAGEAL CANDIDIASIS 98 0.0246
310 LARGE INTESTINE POLYP 170 0.0245
311 IRON DEFICIENCY ANAEMIA 226 0.0245
312 COLITIS 910 0.0240
313 OBSTRUCTIVE AIRWAYS DISORDER 267 0.0240
314 APPENDICECTOMY 85 0.0238
315 CHRONIC GRAFT VERSUS HOST DISEASE 86 0.0238
316 INFLAMMATORY MARKER INCREASED 118 0.0238
317 INTESTINAL PERFORATION 267 0.0238
318 RENAL CELL CARCINOMA 116 0.0237
319 MATERNAL EXPOSURE DURING BREAST FEEDING 96 0.0236
320 MYOSITIS 211 0.0235
321 PANCYTOPENIA 1311 0.0234
322 JOINT EFFUSION 161 0.0233
323 LUNG INFILTRATION 206 0.0233
324 MYOPATHY 201 0.0232
325 SUSPECTED OFF LABEL USE 105 0.0232
326 MUSCULOSKELETAL STIFFNESS 2033 0.0232
327 JOINT SWELLING 2777 0.0230
328 WHEEZING 1354 0.0228
329 PULMONARY MASS 339 0.0227
330 SKIN INFECTION 254 0.0226
331 ADVERSE REACTION 300 0.0226
332 ARTHRITIS 1768 0.0225
333 CONDITION AGGRAVATED 6807 0.0224
334 GASTROINTESTINAL INFECTION 200 0.0223
335 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1071 0.0223
336 SCLERODERMA 81 0.0223
337 ENTEROCOCCAL INFECTION 107 0.0221
338 NEONATAL RESPIRATORY DISTRESS SYNDROME 78 0.0220
339 PROTEINURIA 419 0.0220
340 PRESCRIBED OVERDOSE 426 0.0220
341 STAPHYLOCOCCAL SEPSIS 108 0.0219
342 HEPATOTOXICITY 487 0.0219
343 PANCREATITIS 1153 0.0218
344 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 83 0.0217
345 SKIN ULCER 555 0.0214
346 HYPERCALCAEMIA 260 0.0210
347 MOBILITY DECREASED 1502 0.0209
348 PYELONEPHRITIS 181 0.0209
349 STOMATITIS 1262 0.0208
350 UPPER RESPIRATORY TRACT INFECTION 956 0.0207
351 EOSINOPHIL COUNT INCREASED 172 0.0206
352 DISEASE RECURRENCE 979 0.0206
353 THERAPY PARTIAL RESPONDER 321 0.0206
354 RECTAL HAEMORRHAGE 880 0.0205
355 WEIGHT FLUCTUATION 213 0.0203
356 MUSCULOSKELETAL PAIN 1066 0.0203
357 BLISTER 1135 0.0202
358 SARCOIDOSIS 96 0.0202
359 GESTATIONAL DIABETES 96 0.0201
360 BONE MARROW FAILURE 408 0.0201
361 TASTE DISORDER 407 0.0200
362 EPILEPSY 613 0.0200
363 INFLAMMATORY BOWEL DISEASE 196 0.0200
364 ABSCESS LIMB 85 0.0199
365 INFUSION SITE EXTRAVASATION 124 0.0199
366 HEART RATE DECREASED 699 0.0199
367 KNEE ARTHROPLASTY 419 0.0199
368 BACTERAEMIA 236 0.0199
369 IMMUNE THROMBOCYTOPENIA 91 0.0199
370 REBOUND EFFECT 224 0.0198
371 GRAFT VERSUS HOST DISEASE 142 0.0197
372 HAEMOLYSIS 152 0.0197
373 GASTROINTESTINAL DISORDER 1751 0.0195
374 ESCHERICHIA URINARY TRACT INFECTION 83 0.0195
375 FUNGAL SKIN INFECTION 78 0.0193
376 FLANK PAIN 181 0.0193
377 TENDERNESS 200 0.0192
378 ANKYLOSING SPONDYLITIS 251 0.0190
379 ARTHRITIS BACTERIAL 78 0.0190
380 PREGNANCY 380 0.0190
381 HEPATITIS B 113 0.0187
382 SPLENOMEGALY 218 0.0186
383 FOETAL DEATH 96 0.0185
384 HERPES ZOSTER 1059 0.0184
385 HEPATITIS CHOLESTATIC 111 0.0184
386 ARTERIOSCLEROSIS 173 0.0184
387 MOUTH ULCERATION 386 0.0183
388 OPTIC NEURITIS 166 0.0183
389 ESCHERICHIA INFECTION 150 0.0182
390 ABDOMINAL HERNIA 83 0.0182
391 PNEUMONIA BACTERIAL 167 0.0182
392 CANDIDA INFECTION 306 0.0181
393 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 994 0.0181
394 NEUTROPHIL COUNT INCREASED 185 0.0180
395 MYELODYSPLASTIC SYNDROME 261 0.0180
396 UROSEPSIS 166 0.0180
397 FAECES SOFT 130 0.0179
398 NEPHROPATHY TOXIC 200 0.0178
399 COVID-19 PNEUMONIA 210 0.0178
400 IMMUNODEFICIENCY 265 0.0178
401 IMPAIRED GASTRIC EMPTYING 242 0.0177
402 LIVER DISORDER 786 0.0177
403 ABDOMINAL TENDERNESS 88 0.0177
404 HERPES VIRUS INFECTION 101 0.0175
405 RHINITIS 141 0.0175
406 CYTOPENIA 214 0.0175
407 THERAPEUTIC RESPONSE SHORTENED 579 0.0174
408 ULCER HAEMORRHAGE 118 0.0174
409 BREAST CANCER STAGE II 145 0.0174
410 NECROSIS 97 0.0174
411 INFECTION 2522 0.0174
412 INJECTION SITE INFLAMMATION 86 0.0172
413 MENINGITIS 115 0.0172
414 THERAPEUTIC RESPONSE DECREASED 1043 0.0172
415 ABDOMINAL PAIN 3973 0.0171
416 FOETAL EXPOSURE DURING PREGNANCY 1388 0.0171
417 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 162 0.0170
418 BLOOD ALBUMIN DECREASED 134 0.0169
419 MALNUTRITION 188 0.0168
420 SEPTIC SHOCK 730 0.0168
421 MULTIPLE ORGAN DYSFUNCTION SYNDROME 471 0.0166
422 DISSEMINATED INTRAVASCULAR COAGULATION 233 0.0165
423 CAESAREAN SECTION 192 0.0165
424 ATELECTASIS 159 0.0164
425 ILL-DEFINED DISORDER 997 0.0164
426 BOWEL MOVEMENT IRREGULARITY 124 0.0162
427 DYSLIPIDAEMIA 82 0.0161
428 CLOSTRIDIUM DIFFICILE COLITIS 171 0.0161
429 PHARYNGITIS 200 0.0161
430 ODYNOPHAGIA 96 0.0161
431 DISCOMFORT 981 0.0161
432 GENERAL PHYSICAL HEALTH DETERIORATION 1857 0.0160
433 GASTROENTERITIS 234 0.0160
434 BLOOD IRON DECREASED 190 0.0160
435 ENDOCARDITIS 82 0.0160
436 LARGE INTESTINE PERFORATION 111 0.0160
437 INTERSTITIAL LUNG DISEASE 772 0.0159
438 OFF LABEL USE 13945 0.0159
439 NEPHROTIC SYNDROME 109 0.0159
440 SWELLING 1486 0.0159
441 APPENDICITIS 148 0.0158
442 HYPOALBUMINAEMIA 123 0.0158
443 ANAL INCONTINENCE 141 0.0157
444 STREPTOCOCCAL INFECTION 87 0.0156
445 PANCREATITIS ACUTE 350 0.0156
446 ENCEPHALITIS 107 0.0155
447 SEPSIS 1713 0.0153
448 CYST 189 0.0152
449 ORAL CANDIDIASIS 200 0.0152
450 RALES 88 0.0151
451 LYMPHADENOPATHY 536 0.0151
452 PRODUCTIVE COUGH 721 0.0151
453 HAEMOPTYSIS 421 0.0151
454 FEAR OF INJECTION 107 0.0150
455 SPUTUM DISCOLOURED 142 0.0150
456 INJURY 1052 0.0150
457 LYMPHOMA 231 0.0149
458 MUSCULAR WEAKNESS 1682 0.0148
459 SINUSITIS 1516 0.0148
460 HEART RATE IRREGULAR 333 0.0147
461 PLEURISY 87 0.0146
462 ABNORMAL FAECES 120 0.0146
463 SLEEP DISORDER 1033 0.0146
464 ARTHRALGIA 6066 0.0146
465 DELIRIUM 506 0.0146
466 RESPIRATORY DISORDER 434 0.0145
467 ACUTE MYELOID LEUKAEMIA 224 0.0144
468 NECK PAIN 798 0.0143
469 OEDEMA 774 0.0143
470 TRANSAMINASES INCREASED 317 0.0142
471 HYPERTRANSAMINASAEMIA 99 0.0142
472 MALIGNANT MELANOMA 189 0.0141
473 SKIN LESION 385 0.0140
474 ROAD TRAFFIC ACCIDENT 587 0.0140
475 OSTEOMYELITIS 251 0.0138
476 SKIN CANCER 298 0.0138
477 HYPERSENSITIVITY 2568 0.0138
478 PNEUMONIA 4448 0.0137
479 BACTERIAL INFECTION 256 0.0137
480 NASOPHARYNGITIS 2527 0.0137
481 WEIGHT INCREASED 3068 0.0137
482 HEPATIC FUNCTION ABNORMAL 508 0.0136
483 POSTOPERATIVE WOUND INFECTION 91 0.0135
484 RASH PUSTULAR 98 0.0134
485 HYPERTENSION 2837 0.0134
486 TOOTH INFECTION 176 0.0133
487 NEPHROLITHIASIS 611 0.0133
488 STAPHYLOCOCCAL INFECTION 434 0.0131
489 POLYP 86 0.0131
490 HYPOAESTHESIA 1964 0.0131
491 LIPASE INCREASED 100 0.0130
492 CONCUSSION 101 0.0130
493 POST PROCEDURAL INFECTION 106 0.0130
494 TYPE 1 DIABETES MELLITUS 78 0.0129
495 PRODUCT USE ISSUE 2430 0.0129
496 VIRAL INFECTION 428 0.0128
497 DRUG RESISTANCE 330 0.0128
498 DISABILITY 254 0.0128
499 PERIPHERAL SWELLING 1976 0.0128
500 RESPIRATORY TRACT INFECTION 334 0.0128
501 HEPATOMEGALY 126 0.0128
502 WEIGHT DECREASED 3569 0.0128
503 ABORTION SPONTANEOUS 511 0.0127
504 PYREXIA 4404 0.0127
505 ABDOMINAL DISCOMFORT 2134 0.0127
506 TONGUE DISORDER 92 0.0127
507 CONJUNCTIVITIS 235 0.0127
508 PHARYNGITIS STREPTOCOCCAL 137 0.0126
509 PURPURA 112 0.0126
510 HYPOTHYROIDISM 404 0.0126
511 RENAL TUBULAR NECROSIS 124 0.0126
512 EAR PAIN 245 0.0126
513 POST PROCEDURAL COMPLICATION 242 0.0126
514 VITAMIN D DECREASED 107 0.0125
515 DRUG LEVEL INCREASED 207 0.0125
516 ACUTE RESPIRATORY DISTRESS SYNDROME 220 0.0124
517 OVARIAN CYST 124 0.0124
518 GASTROOESOPHAGEAL REFLUX DISEASE 993 0.0123
519 LOCALISED INFECTION 296 0.0122
520 RENAL IMPAIRMENT 1024 0.0122
521 NEUTROPENIC SEPSIS 87 0.0122
522 TOOTH ABSCESS 124 0.0122
523 UTERINE LEIOMYOMA 89 0.0122
524 ABDOMINAL PAIN LOWER 307 0.0121
525 MUSCLE SPASTICITY 149 0.0121
526 DRY MOUTH 982 0.0121
527 GASTROINTESTINAL PAIN 133 0.0121
528 BODY TEMPERATURE INCREASED 246 0.0120
529 MIGRAINE 1146 0.0120
530 ANAPHYLACTIC REACTION 662 0.0120
531 DECREASED IMMUNE RESPONSIVENESS 117 0.0119
532 ALOPECIA 2324 0.0118
533 PLATELET COUNT INCREASED 153 0.0117
534 INFUSION SITE PAIN 151 0.0117
535 ABDOMINAL DISTENSION 1223 0.0117
536 PRODUCT USE IN UNAPPROVED INDICATION 2897 0.0117
537 BRONCHITIS 861 0.0116
538 ALANINE AMINOTRANSFERASE INCREASED 714 0.0116
539 MULTI-ORGAN FAILURE 201 0.0116
540 FURUNCLE 92 0.0116
541 ATRIAL SEPTAL DEFECT 97 0.0116
542 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2086 0.0116
543 DYSPEPSIA 1138 0.0116
544 SINUS CONGESTION 156 0.0115
545 KIDNEY INFECTION 225 0.0115
546 IMPAIRED WORK ABILITY 245 0.0114
547 RESPIRATORY FAILURE 827 0.0113
548 ARTHROPOD BITE 84 0.0113
549 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 291 0.0113
550 HYDRONEPHROSIS 84 0.0112
551 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 191 0.0111
552 PETECHIAE 116 0.0111
553 OSTEONECROSIS 365 0.0111
554 ASPARTATE AMINOTRANSFERASE INCREASED 590 0.0111
555 RENAL CYST 88 0.0111
556 WHITE BLOOD CELL COUNT INCREASED 425 0.0111
557 OESOPHAGITIS 121 0.0111
558 HAEMODIALYSIS 93 0.0111
559 INFLUENZA 1225 0.0110
560 FUNGAL INFECTION 366 0.0110
561 QUALITY OF LIFE DECREASED 147 0.0109
562 URTICARIA 1829 0.0109
563 ASTHMA 1228 0.0109
564 HEPATIC STEATOSIS 202 0.0108
565 EYE INFLAMMATION 103 0.0108
566 ASCITES 317 0.0108
567 OROPHARYNGEAL PAIN 998 0.0108
568 PULMONARY HAEMORRHAGE 84 0.0107
569 HAEMATOTOXICITY 102 0.0107
570 HAEMORRHOIDS 209 0.0107
571 LIVER FUNCTION TEST ABNORMAL 311 0.0107
572 URINARY TRACT INFECTION 1810 0.0106
573 DEVICE RELATED INFECTION 163 0.0106
574 MYELOSUPPRESSION 381 0.0106
575 SKIN LACERATION 115 0.0106
576 PAIN IN EXTREMITY 3102 0.0105
577 BLOOD CREATININE INCREASED 686 0.0105
578 DIABETES MELLITUS 799 0.0105
579 SPINAL OSTEOARTHRITIS 92 0.0105
580 CHOLESTASIS 201 0.0105
581 GROIN PAIN 91 0.0104
582 DERMATITIS 217 0.0103
583 MUSCULOSKELETAL DISCOMFORT 178 0.0103
584 HYPOXIA 364 0.0103
585 SENSORY LOSS 83 0.0103
586 HIDRADENITIS 94 0.0103
587 MYOCARDITIS 118 0.0103
588 CARPAL TUNNEL SYNDROME 144 0.0103
589 RENAL FAILURE CHRONIC 79 0.0103
590 RESPIRATORY RATE INCREASED 91 0.0102
591 DRUG INEFFECTIVE 13478 0.0102
592 OEDEMA PERIPHERAL 1237 0.0101
593 CELLULITIS 511 0.0101
594 HYPERBILIRUBINAEMIA 105 0.0101
595 CONTUSION 969 0.0101
596 ILEUS 125 0.0100
597 PHOTOSENSITIVITY REACTION 166 0.0100
598 ORAL HERPES 195 0.0100
599 LABORATORY TEST ABNORMAL 293 0.0099
600 RASH MACULO-PAPULAR 220 0.0099
601 MUSCULOSKELETAL DISORDER 187 0.0098
602 HAEMOLYTIC ANAEMIA 88 0.0098
603 ADRENAL INSUFFICIENCY 119 0.0098
604 SKIN DISORDER 327 0.0098
605 DIVERTICULITIS 271 0.0098
606 DEFORMITY 91 0.0097
607 INJECTION SITE REACTION 669 0.0097
608 HERNIA 187 0.0097
609 CHOLELITHIASIS 317 0.0097
610 TUBULOINTERSTITIAL NEPHRITIS 181 0.0096
611 RED BLOOD CELL COUNT DECREASED 276 0.0096
612 HAEMOGLOBIN DECREASED 985 0.0096
613 PNEUMOTHORAX 152 0.0096
614 CHOLECYSTECTOMY 109 0.0095
615 MASS 133 0.0095
616 MUSCLE SPASMS 1744 0.0095
617 COVID-19 1664 0.0095
618 OXYGEN SATURATION DECREASED 533 0.0095
619 OSTEOPENIA 143 0.0094
620 BLOOD PRESSURE INCREASED 1435 0.0094
621 EYE INFECTION 105 0.0093
622 MITRAL VALVE INCOMPETENCE 105 0.0093
623 ANAEMIA 1766 0.0093
624 VISUAL IMPAIRMENT 1147 0.0092
625 GOUT 165 0.0092
626 SECRETION DISCHARGE 115 0.0092
627 GASTRIC ULCER 174 0.0091
628 NASAL CONGESTION 537 0.0091
629 ABDOMINAL PAIN UPPER 1880 0.0091
630 COLON CANCER 136 0.0091
631 BLOOD LACTATE DEHYDROGENASE INCREASED 143 0.0090
632 VITAMIN D DEFICIENCY 88 0.0090
633 COAGULOPATHY 150 0.0090
634 JAUNDICE 242 0.0090
635 DIARRHOEA 5805 0.0090
636 LEUKOCYTOSIS 162 0.0089
637 AMNESIA 582 0.0089
638 MALAISE 3922 0.0089
639 PHOTOPHOBIA 167 0.0089
640 PAIN IN JAW 251 0.0089
641 EYELID PTOSIS 90 0.0088
642 ATAXIA 105 0.0088
643 WHITE BLOOD CELL COUNT DECREASED 959 0.0088
644 PERITONITIS 183 0.0088
645 MEMORY IMPAIRMENT 1212 0.0088
646 RASH PRURITIC 477 0.0088
647 TENDONITIS 136 0.0088
648 THROMBOCYTOPENIA 980 0.0088
649 GLAUCOMA 168 0.0087
650 TACHYCARDIA 771 0.0087
651 IMPAIRED QUALITY OF LIFE 124 0.0086
652 PARAESTHESIA 1350 0.0086
653 IMMUNE SYSTEM DISORDER 113 0.0086
654 GASTRITIS 225 0.0085
655 GASTROENTERITIS VIRAL 154 0.0085
656 CHEST PAIN 1574 0.0085
657 RESPIRATORY TRACT CONGESTION 135 0.0085
658 MULTIPLE SCLEROSIS RELAPSE 582 0.0085
659 HEPATIC FAILURE 256 0.0085
660 THROMBOSIS 683 0.0085
661 RETINAL DETACHMENT 78 0.0085
662 GENERALISED OEDEMA 105 0.0085
663 MUSCLE ATROPHY 107 0.0084
664 RASH 3676 0.0084
665 JOINT INJURY 179 0.0084
666 CONFUSIONAL STATE 1352 0.0084
667 NEOPLASM 96 0.0083
668 CATARACT 497 0.0083
669 HEADACHE 5218 0.0083
670 HAEMATURIA 284 0.0083
671 ADVERSE DRUG REACTION 744 0.0083
672 HAEMATOCRIT DECREASED 164 0.0083
673 VOMITING 3885 0.0083
674 LIMB DISCOMFORT 255 0.0082
675 LUNG INFECTION 128 0.0082
676 ACUTE HEPATIC FAILURE 112 0.0082
677 ACUTE RESPIRATORY FAILURE 157 0.0082
678 INTERVERTEBRAL DISC PROTRUSION 178 0.0081
679 BLOOD ALKALINE PHOSPHATASE INCREASED 201 0.0081
680 TOOTH FRACTURE 89 0.0081
681 HEMIPARESIS 136 0.0080
682 RIB FRACTURE 165 0.0080
683 AGRANULOCYTOSIS 149 0.0080
684 DECREASED APPETITE 1856 0.0080
685 ASTHENIA 2965 0.0079
686 CYSTITIS 251 0.0079
687 SKIN REACTION 111 0.0079
688 DRUG EFFECT INCOMPLETE 286 0.0079
689 MULTIPLE SCLEROSIS 376 0.0079
690 SPINAL PAIN 92 0.0078
691 RHINORRHOEA 507 0.0078
692 BLOOD TEST ABNORMAL 110 0.0078
693 SCAR 134 0.0078
694 FATIGUE 6093 0.0078
695 HYPOPHAGIA 200 0.0078
696 PLEURAL EFFUSION 474 0.0078
697 ADVERSE EVENT 717 0.0078
698 NEUTROPENIA 1057 0.0078
699 SEASONAL ALLERGY 110 0.0078
700 COUGH 2154 0.0077
701 DRUG INTERACTION 1218 0.0077
702 DYSPNOEA EXERTIONAL 288 0.0076
703 DRUG EXPOSURE DURING PREGNANCY 260 0.0076
704 CHILLS 896 0.0076
705 HYPERLIPIDAEMIA 91 0.0076
706 PULMONARY HYPERTENSION 158 0.0076
707 FEELING HOT 465 0.0076
708 HEART RATE INCREASED 750 0.0076
709 EPISTAXIS 565 0.0075
710 RESPIRATORY DISTRESS 208 0.0075
711 CENTRAL NERVOUS SYSTEM LESION 103 0.0075
712 HEPATITIS C 90 0.0074
713 PULMONARY EMBOLISM 702 0.0074
714 PAIN 4503 0.0073
715 INFLUENZA LIKE ILLNESS 603 0.0073
716 GAIT DISTURBANCE 1401 0.0073
717 DIPLOPIA 190 0.0073
718 FEBRILE NEUTROPENIA 483 0.0073
719 GAMMA-GLUTAMYLTRANSFERASE INCREASED 161 0.0073
720 NAUSEA 5745 0.0073
721 DEPRESSION 1609 0.0071
722 RASH PAPULAR 158 0.0070
723 DYSPNOEA 3978 0.0070
724 SCAB 80 0.0070
725 PERICARDIAL EFFUSION 161 0.0070
726 PERIPHERAL COLDNESS 95 0.0069
727 SINUS DISORDER 137 0.0069
728 BLOOD POTASSIUM DECREASED 208 0.0069
729 FEEDING DISORDER 140 0.0069
730 END STAGE RENAL DISEASE 125 0.0068
731 EOSINOPHILIA 120 0.0068
732 TOOTH EXTRACTION 85 0.0068
733 NO THERAPEUTIC RESPONSE 83 0.0068
734 DERMATITIS ALLERGIC 85 0.0068
735 PALLOR 183 0.0067
736 MUSCULOSKELETAL CHEST PAIN 104 0.0067
737 FACE OEDEMA 113 0.0067
738 POOR QUALITY SLEEP 143 0.0066
739 HIATUS HERNIA 86 0.0066
740 DISEASE PROGRESSION 785 0.0066
741 FLATULENCE 376 0.0066
742 TOOTHACHE 120 0.0066
743 APHONIA 92 0.0066
744 SARS-COV-2 TEST POSITIVE 87 0.0066
745 BRAIN OEDEMA 83 0.0066
746 INTENTIONAL DOSE OMISSION 187 0.0066
747 BLOOD PRESSURE DECREASED 434 0.0065
748 THROAT IRRITATION 293 0.0065
749 DEEP VEIN THROMBOSIS 424 0.0065
750 WRIST FRACTURE 78 0.0065
751 METASTASES TO LIVER 113 0.0064
752 BLOOD CREATINE PHOSPHOKINASE INCREASED 185 0.0064
753 DRUG EFFECT DECREASED 345 0.0064
754 FEELING JITTERY 122 0.0064
755 NEURALGIA 155 0.0064
756 NEOPLASM MALIGNANT 425 0.0064
757 UNDERDOSE 464 0.0064
758 PNEUMONITIS 173 0.0063
759 BLOOD UREA INCREASED 106 0.0063
760 TACHYPNOEA 86 0.0063
761 INSOMNIA 1682 0.0063
762 BONE DISORDER 115 0.0063
763 SHOCK 145 0.0063
764 MYALGIA 1069 0.0063
765 FOOT FRACTURE 119 0.0063
766 ERYTHEMA 1281 0.0062
767 ACUTE KIDNEY INJURY 952 0.0062
768 BACK PAIN 1441 0.0062
769 INJECTION SITE HAEMATOMA 90 0.0062
770 RENAL FAILURE 813 0.0061
771 APHASIA 184 0.0061
772 ENCEPHALOPATHY 149 0.0061
773 SWELLING FACE 395 0.0061
774 PSORIASIS 789 0.0060
775 PARAESTHESIA ORAL 87 0.0060
776 CARDIOVASCULAR DISORDER 153 0.0060
777 PRURITUS 2315 0.0060
778 PRODUCT PRESCRIBING ISSUE 131 0.0060
779 SURGERY 352 0.0060
780 GASTRIC DISORDER 206 0.0060
781 GALLBLADDER DISORDER 107 0.0060
782 HYPERKALAEMIA 209 0.0060
783 MELAENA 131 0.0059
784 PARALYSIS 85 0.0059
785 DEHYDRATION 791 0.0059
786 DIZZINESS 2943 0.0059
787 TOOTH DISORDER 131 0.0059
788 BLOOD BILIRUBIN INCREASED 159 0.0059
789 DYSURIA 216 0.0059
790 HYPOKINESIA 85 0.0058
791 CHROMATURIA 132 0.0058
792 PLATELET COUNT DECREASED 617 0.0058
793 EATING DISORDER 123 0.0058
794 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 168 0.0057
795 SENSORY DISTURBANCE 92 0.0057
796 PROCEDURAL PAIN 159 0.0057
797 COLD SWEAT 101 0.0057
798 ANGIOEDEMA 252 0.0057
799 BLOOD URINE PRESENT 108 0.0057
800 TREATMENT NONCOMPLIANCE 310 0.0057
801 RENAL FAILURE ACUTE 240 0.0057
802 HAEMORRHAGE 590 0.0056
803 ANXIETY 1600 0.0056
804 CARDIOMYOPATHY 83 0.0056
805 DEAFNESS 146 0.0056
806 EYE PAIN 315 0.0056
807 UPPER LIMB FRACTURE 111 0.0056
808 RASH ERYTHEMATOUS 266 0.0056
809 FAECES DISCOLOURED 120 0.0055
810 SKIN DISCOLOURATION 254 0.0055
811 HYPOKALAEMIA 255 0.0055
812 HAEMATEMESIS 140 0.0055
813 THYROID DISORDER 84 0.0054
814 HYPOAESTHESIA ORAL 82 0.0054
815 CHEST DISCOMFORT 554 0.0054
816 SPINAL FRACTURE 108 0.0054
817 HYPOTENSION 1079 0.0054
818 ILLNESS 554 0.0054
819 ANKLE FRACTURE 83 0.0054
820 PRODUCT PRESCRIBING ERROR 127 0.0053
821 EYE DISORDER 175 0.0053
822 LIMB INJURY 144 0.0053
823 PRESYNCOPE 128 0.0053
824 CEREBRAL INFARCTION 128 0.0052
825 OCULAR HYPERAEMIA 245 0.0052
826 SLEEP APNOEA SYNDROME 98 0.0051
827 NERVOUS SYSTEM DISORDER 160 0.0051
828 DYSPHAGIA 485 0.0051
829 THROAT TIGHTNESS 138 0.0051
830 MEDICATION ERROR 281 0.0051
831 DRY EYE 252 0.0050
832 MENTAL DISORDER 218 0.0050
833 FEELING COLD 139 0.0050
834 BLOOD TRIGLYCERIDES INCREASED 88 0.0050
835 MUCOSAL INFLAMMATION 130 0.0050
836 RENAL DISORDER 231 0.0050
837 FALL 1647 0.0049
838 LETHARGY 283 0.0049
839 ECZEMA 255 0.0049
840 NEUROTOXICITY 85 0.0048
841 DYSSTASIA 141 0.0048
842 CIRCULATORY COLLAPSE 82 0.0048
843 MOVEMENT DISORDER 154 0.0048
844 VERTIGO 290 0.0048
845 INJECTION SITE PAIN 1458 0.0047
846 PRODUCT ADMINISTRATION ERROR 96 0.0047
847 FLUID RETENTION 240 0.0047
848 RASH MACULAR 164 0.0047
849 CONSTIPATION 1021 0.0047
850 PALPITATIONS 548 0.0047
851 HYPERGLYCAEMIA 170 0.0047
852 NEUROPATHY PERIPHERAL 443 0.0047
853 PRODUCT AVAILABILITY ISSUE 106 0.0047
854 THIRST 83 0.0046
855 DYSARTHRIA 174 0.0046
856 INJECTION SITE PRURITUS 309 0.0046
857 ACUTE MYOCARDIAL INFARCTION 136 0.0046
858 LOCAL SWELLING 80 0.0046
859 RHABDOMYOLYSIS 190 0.0046
860 INCORRECT DOSE ADMINISTERED 1034 0.0045
861 HYPOCALCAEMIA 85 0.0045
862 PULMONARY OEDEMA 201 0.0045
863 URINARY INCONTINENCE 132 0.0045
864 INJECTION SITE BRUISING 355 0.0044
865 HYPERSOMNIA 126 0.0044
866 SYNCOPE 435 0.0043
867 WRONG TECHNIQUE IN DRUG USAGE PROCESS 157 0.0043
868 GASTROINTESTINAL HAEMORRHAGE 359 0.0043
869 BURNING SENSATION 301 0.0043
870 HAEMATOMA 110 0.0042
871 CHRONIC KIDNEY DISEASE 320 0.0042
872 BLINDNESS 171 0.0042
873 DEPRESSED MOOD 221 0.0042
874 SNEEZING 93 0.0041
875 ACNE 314 0.0041
876 ARRHYTHMIA 196 0.0041
877 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 291 0.0041
878 SWOLLEN TONGUE 127 0.0041
879 BONE DENSITY DECREASED 127 0.0040
880 COGNITIVE DISORDER 189 0.0040
881 ORAL PAIN 90 0.0040
882 THERAPEUTIC RESPONSE UNEXPECTED 180 0.0040
883 NEUTROPHIL COUNT DECREASED 162 0.0040
884 FEELING ABNORMAL 944 0.0039
885 SPEECH DISORDER 206 0.0039
886 CARDIAC FAILURE 315 0.0039
887 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
888 FLUSHING 397 0.0039
889 DYSPHONIA 228 0.0039
890 INJECTION SITE ERYTHEMA 483 0.0039
891 BALANCE DISORDER 335 0.0039
892 LOSS OF CONSCIOUSNESS 496 0.0039
893 CORONARY ARTERY DISEASE 117 0.0039
894 ABASIA 95 0.0038
895 PRURITUS GENERALISED 82 0.0038
896 METABOLIC ACIDOSIS 121 0.0038
897 ATRIAL FIBRILLATION 368 0.0038
898 CEREBRAL HAEMORRHAGE 135 0.0038
899 PNEUMONIA ASPIRATION 94 0.0038
900 INJECTION SITE URTICARIA 92 0.0037
901 MENTAL STATUS CHANGES 104 0.0037
902 UNEVALUABLE EVENT 282 0.0037
903 SEIZURE 430 0.0037
904 TINNITUS 170 0.0037
905 HYPERHIDROSIS 475 0.0037
906 LIP SWELLING 120 0.0036
907 PANIC ATTACK 131 0.0036
908 INJECTION SITE HAEMORRHAGE 283 0.0035
909 EYE SWELLING 131 0.0035
910 ANGINA PECTORIS 100 0.0035
911 HOSPITALISATION 535 0.0035
912 LUNG NEOPLASM MALIGNANT 143 0.0035
913 VISION BLURRED 476 0.0035
914 TREMOR 573 0.0034
915 HEAD INJURY 109 0.0034
916 TOXICITY TO VARIOUS AGENTS 580 0.0034
917 NERVOUSNESS 178 0.0034
918 INTERNATIONAL NORMALISED RATIO INCREASED 97 0.0034
919 BONE PAIN 197 0.0034
920 FEMUR FRACTURE 104 0.0034
921 EYE IRRITATION 193 0.0033
922 INJECTION SITE RASH 102 0.0033
923 OVERDOSE 710 0.0033
924 PSYCHOTIC DISORDER 96 0.0032
925 SKIN EXFOLIATION 270 0.0032
926 LACRIMATION INCREASED 96 0.0032
927 ANAPHYLACTIC SHOCK 81 0.0031
928 HIP FRACTURE 101 0.0031
929 HOT FLUSH 236 0.0031
930 AGEUSIA 78 0.0031
931 POLLAKIURIA 130 0.0031
932 VAGINAL HAEMORRHAGE 135 0.0031
933 INJECTION SITE SWELLING 237 0.0031
934 URINARY RETENTION 102 0.0031
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 159 0.0030
936 PRODUCT QUALITY ISSUE 410 0.0030
937 CARDIAC ARREST 249 0.0030
938 TRANSIENT ISCHAEMIC ATTACK 100 0.0030
939 BREAST CANCER 276 0.0030
940 BREAST CANCER FEMALE 79 0.0030
941 SOMNOLENCE 592 0.0029
942 BRADYCARDIA 155 0.0029
943 HYPONATRAEMIA 163 0.0029
944 VISUAL ACUITY REDUCED 96 0.0029
945 HYPOGLYCAEMIA 138 0.0028
946 CRYING 99 0.0027
947 CARDIAC DISORDER 253 0.0027
948 PRODUCT DOSE OMISSION ISSUE 780 0.0026
949 COMA 125 0.0026
950 CONVULSION 150 0.0026
951 MYOCARDIAL INFARCTION 456 0.0026
952 DEPRESSED LEVEL OF CONSCIOUSNESS 103 0.0026
953 LACTIC ACIDOSIS 84 0.0026
954 CEREBROVASCULAR ACCIDENT 436 0.0026
955 DISORIENTATION 101 0.0025
956 DEVICE MALFUNCTION 175 0.0025
957 THERAPY INTERRUPTED 177 0.0025
958 HYPOACUSIS 106 0.0025
959 DEVICE ISSUE 219 0.0024
960 ELECTROCARDIOGRAM QT PROLONGED 87 0.0024
961 DISTURBANCE IN ATTENTION 128 0.0024
962 NEOPLASM PROGRESSION 78 0.0022
963 CARDIAC FAILURE CONGESTIVE 178 0.0022
964 SUICIDAL IDEATION 198 0.0022
965 IRRITABILITY 130 0.0022
966 INTENTIONAL PRODUCT MISUSE 189 0.0022
967 DRY SKIN 287 0.0021
968 CARDIO-RESPIRATORY ARREST 88 0.0021
969 DYSGEUSIA 153 0.0021
970 DRUG DOSE OMISSION 329 0.0020
971 AGITATION 138 0.0019
972 THERAPY CESSATION 94 0.0018
973 BLOOD GLUCOSE INCREASED 344 0.0018
974 PRODUCT DOSE OMISSION 119 0.0018
975 HALLUCINATION 136 0.0018
976 NO ADVERSE EVENT 324 0.0018
977 DEATH 1498 0.0017
978 SUICIDE ATTEMPT 98 0.0016
979 PROSTATE CANCER 125 0.0016
980 DRUG DEPENDENCE 213 0.0013
981 INTENTIONAL OVERDOSE 81 0.0013
982 SKIN BURNING SENSATION 82 0.0011
983 EMOTIONAL DISTRESS 136 0.0011
984 MALIGNANT NEOPLASM PROGRESSION 106 0.0010
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 172 0.0008